This is consistent with the matching here of p-60-MDM2 pfeRNA with an antisense small nucleolar RNA fragment and a sense 18S rRNA fragment, and the effects of this pfeRNA on cancer cell apoptosis and chemoresistance to cisplatin-based therapy [15]. The gene discussed is MDM2; the disease is cancer.